SONN
Price:
$1.56
Market Cap:
$4.69M
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreeme...[Read more]
Industry
Biotechnology
IPO Date
2006-10-31
Stock Exchange
NASDAQ
Ticker
SONN
According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.67M. This represents a change of -88.06% compared to the average of 39.14M of the last 4 quarters.
The mean historical Enterprise Value of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is 77.37M. The current 4.67M Enterprise Value has changed 504.01% with respect to the historical average. Over the past ten years (40 quarters), SONN's Enterprise Value was at its highest in in the June 2018 quarter at 690.45B. The Enterprise Value was at its lowest in in the December 2014 quarter at 0.
Average
77.37M
Median
55.21M
Minimum
4.36M
Maximum
189.85M
Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 361.84%
Maximum Annual Enterprise Value = 189.85M
Minimum Annual Increase = -79.91%
Minimum Annual Enterprise Value = 4.36M
Year | Enterprise Value | Change |
---|---|---|
2024 | 4.36M | -79.91% |
2023 | 21.72M | -54.96% |
2022 | 48.24M | -47.22% |
2021 | 91.39M | -50.99% |
2020 | 186.49M | 361.84% |
2019 | 40.38M | -12.35% |
2018 | 46.07M | -25.90% |
2017 | 62.17M | -25.07% |
2016 | 82.98M | -56.29% |
2015 | 189.85M | -10.31% |
The current Enterprise Value of Sonnet BioTherapeutics Holdings, Inc. (SONN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
24.78M
5-year avg
70.44M
10-year avg
77.37M
Sonnet BioTherapeutics Holdings, Inc.’s Enterprise Value is less than YS Biopharma Co., Ltd. (0), less than ZyVersa Therapeutics, Inc. (747.76M), greater than Allarity Therapeutics, Inc. (2.55M), greater than Kiromic BioPharma, Inc. (-12736306.00), less than Immix Biopharma, Inc. (13.21M), less than CNS Pharmaceuticals, Inc. (41.09M), greater than eFFECTOR Therapeutics, Inc. (-733373.00), less than Navidea Biopharmaceuticals, Inc. (4.74M), greater than null (-2595051.00),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $192.09M | |
747.76M | $2.67M | |
2.55M | $4.39M | |
-12736306.00 | $1.42M | |
13.21M | $59.69M | |
41.09M | $6.21M | |
-733373.00 | $941.00 | |
4.74M | $10.01K | |
-2595051.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sonnet BioTherapeutics Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
What is the 3-year average Enterprise Value for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
What is the 5-year average Enterprise Value for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
How does the current Enterprise Value for Sonnet BioTherapeutics Holdings, Inc. (SONN) compare to its historical average?